NM_000686.5:c.402delT

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_000686.5(AGTR2):​c.402delT​(p.Phe134LeufsTer5) variant causes a frameshift change. The variant allele was found at a frequency of 0.000575 in 1,208,062 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 211 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00044 ( 0 hom., 11 hem., cov: 23)
Exomes 𝑓: 0.00059 ( 0 hom. 200 hem. )

Consequence

AGTR2
NM_000686.5 frameshift

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts U:1B:3

Conservation

PhyloP100: 6.16

Publications

7 publications found
Variant links:
Genes affected
AGTR2 (HGNC:338): (angiotensin II receptor type 2) The protein encoded by this gene belongs to the G-protein coupled receptor 1 family, and functions as a receptor for angiotensin II. It is an intergral membrane protein that is highly expressed in fetus and in neonates, but scantily in adult tissues, except brain, adrenal medulla, and atretic ovary. This receptor has been shown to mediate programmed cell death and this apoptotic function may play an important role in developmental biology and pathophysiology. Mutations in this gene are been associated with X-linked cognitive disability. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and SARS-CoV-2 infection results in down-regulation of angiotensin converting enzyme-2 (ACE2) receptors, the effects of which, triggers serious inflammatory lesions in the tissues involved, primarily in the lungs. The inflammatory reaction appears to be mediated by angiotensin II derivatives, including the angiotensin AT2 receptor which has been found to be upregulated in bronchoalveolar lavage samples from Coronavirus disease 2019 (COVID19) patients. [provided by RefSeq, Jul 2020]
AGTR2 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP6
Variant X-116172674-AT-A is Benign according to our data. Variant chrX-116172674-AT-A is described in ClinVar as Likely_benign. ClinVar VariationId is 11717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 11 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGTR2NM_000686.5 linkc.402delT p.Phe134LeufsTer5 frameshift_variant Exon 3 of 3 ENST00000371906.5 NP_000677.2 P50052
AGTR2NM_001385624.1 linkc.402delT p.Phe134LeufsTer5 frameshift_variant Exon 2 of 2 NP_001372553.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGTR2ENST00000371906.5 linkc.402delT p.Phe134LeufsTer5 frameshift_variant Exon 3 of 3 1 NM_000686.5 ENSP00000360973.4 P50052
AGTR2ENST00000681852.1 linkc.402delT p.Phe134LeufsTer5 frameshift_variant Exon 2 of 2 ENSP00000505750.1 P50052
AGTR2ENST00000680409.1 linkn.870delT non_coding_transcript_exon_variant Exon 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.000443
AC:
49
AN:
110551
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000132
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000833
Gnomad OTH
AF:
0.000668
GnomAD2 exomes
AF:
0.000454
AC:
83
AN:
182958
AF XY:
0.000414
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000627
Gnomad NFE exome
AF:
0.000969
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000589
AC:
646
AN:
1097460
Hom.:
0
Cov.:
31
AF XY:
0.000551
AC XY:
200
AN XY:
362940
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26380
American (AMR)
AF:
0.00
AC:
0
AN:
35200
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19371
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54127
European-Finnish (FIN)
AF:
0.000123
AC:
5
AN:
40512
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
0.000739
AC:
622
AN:
841467
Other (OTH)
AF:
0.000391
AC:
18
AN:
46074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000443
AC:
49
AN:
110602
Hom.:
0
Cov.:
23
AF XY:
0.000334
AC XY:
11
AN XY:
32950
show subpopulations
African (AFR)
AF:
0.000132
AC:
4
AN:
30402
American (AMR)
AF:
0.00
AC:
0
AN:
10350
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2625
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3493
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2617
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5899
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
215
European-Non Finnish (NFE)
AF:
0.000833
AC:
44
AN:
52807
Other (OTH)
AF:
0.000659
AC:
1
AN:
1517
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000182
Hom.:
1
Bravo
AF:
0.000461
EpiCase
AF:
0.000382
EpiControl
AF:
0.000593

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 03, 2015
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Aug 08, 2013
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
Jun 01, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

AGTR2-related disorder Benign:1
Mar 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.2
Mutation Taster
=156/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387906503; hg19: chrX-115303927; COSMIC: COSV64156240; API